You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Apolipoprotein B (APOB) Antibodies

APOB product is the main apolipoprotein of chylomicrons and low density lipoproteins. Additionally we are shipping APOB Kits (144) and APOB Proteins (26) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
APOB 338 P04114
APOB 54225 Q7TMA5
APOB 238055  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top anti-APOB Antibodies at

Showing 10 out of 344 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated IHC, WB 100 μL Log in to see 2 to 3 Days
Human Goat Un-conjugated WB 0.1 mg Log in to see 6 to 8 Days
Human Mouse Un-conjugated ICC, FACS, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Flow cytometric analysis of serun using ApoB mouse mAb (green) and negative control (purple) . 100 μL Log in to see 3 to 4 Days
Human Goat HRP EIA, WB   1 mL Log in to see 6 to 8 Days
Human Goat Un-conjugated ELISA, WB 0.1 mg Log in to see 7 to 9 Days
Human Goat Un-conjugated EIA, IP, WB   0.1 mg Log in to see 6 to 8 Days
Human Rabbit Un-conjugated IF (p), IHC (p) Formalin-fixed and paraffin embedded human colon carcinoma labeled with Rabbit Anti ApoB/Apolipoprotein B Polyclonal Antibody, Unconjugated (ABIN872950) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL Log in to see 3 to 7 Days
Human Mouse Un-conjugated EIA, RIA   1 mg Log in to see 6 to 8 Days
Human Mouse Un-conjugated EIA, IF, WB 0.1 mL Log in to see 6 to 8 Days
Human Mouse Un-conjugated EIA, IHC (fro)   1 mL Log in to see 6 to 8 Days

APOB Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
, , , ,
, , , , , , , , , , , , , , , ,
Rat (Rattus) , , ,
, , , , , , , , , , , , ,
Mouse (Murine) , , ,

, , , , , , , , , , , , ,

Top referenced anti-APOB Antibodies

  1. Human Polyclonal APOB Primary Antibody for EIA, WB - ABIN112988 : Herscovitz, Derksen, Walsh, McKnight, Gantz, Hadzopoulou-Cladaras, Zannis, Curry, Small: The N-terminal 17% of apoB binds tightly and irreversibly to emulsions modeling nascent very low density lipoproteins. in Journal of lipid research 2001 (PubMed)
    Show all 6 references for ABIN112988

  2. Human Polyclonal APOB Primary Antibody for EIA, IP - ABIN318832 : Olofsson, Borèn: Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. in Journal of internal medicine 2005 (PubMed)
    Show all 2 references for ABIN318832

  3. Human Monoclonal APOB Primary Antibody for ICC, FACS - ABIN968961 : Peterson, Mack, Hall, Alsup, Alexander, Sully, Sawires, Cheung, Otto, Gresham: Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection. in Cell host & microbe 2008 (PubMed)
    Show all 2 references for ABIN968961

  4. Human Monoclonal APOB Primary Antibody for EIA, IHC (fro) - ABIN1105417 : Valentinova, Gu, Yang, Yanushevskaya, Antonov, Guyton, Smith, Gotto, Yang: Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein. in Biological chemistry Hoppe-Seyler 1995 (PubMed)

  5. Human Monoclonal APOB Primary Antibody for EIA, IF - ABIN1105414 : Benn: Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review. in Atherosclerosis 2009 (PubMed)

  6. Human Polyclonal APOB Primary Antibody for IF (p), IHC (p) - ABIN872950 : Choi, de Poot, Lee, Kim, Han, Kim, Finley, Lee: Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. in Nature communications 2016 (PubMed)

  7. Human Polyclonal APOB Primary Antibody for ELISA, WB - ABIN449695 : Benn, Nordestgaard, Jensen, Tybjaerg-Hansen: Polymorphisms in apolipoprotein B and risk of ischemic stroke. in The Journal of clinical endocrinology and metabolism 2007 (PubMed)

  8. Human Polyclonal APOB Primary Antibody for IHC, WB - ABIN2776957 : Kamdem, Hamilton, Cheng, Liu, Yang, Johnson, Pui, Relling: Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. in Pharmacogenetics and genomics 2008 (PubMed)

More Antibodies against APOB Interaction Partners

Human Apolipoprotein B (APOB) interaction partners

  1. 10 association studies for Han Chinese, with 1195 CHD patients and 1178 healthy subjects, we found that XbaI (rs693) polymorphisms in APOB were statistically significantly associated with Coronary Heart Disease in Han Chinese population

  2. We observed a significant interaction between Ins (show INS Antibodies)/Del ApoB genotype and dietary omega-3 PUFA intake with respect to BMI, WC, and obesity risk in both unadjusted (P = 0.007, P = 0.001, and P = 0.021, respectively) and adjusted (P = 0.007, P = 0.04, and P = 0.002, respectively) samples in NIDDM patients.

  3. Compared with healthy controls, preeclamptic patients had significantly lower Apo A (show APOA Antibodies)-1 levels (167.07mg/dl+/-14.61mg/dl vs. 244.37mg/dl+/-20.84mg/dl, p<0.001), higher Apo B-100/Apo A (show APOA Antibodies)-1 ratio (0.63+/-0.07 vs. 0.42+/-0.05, p<0.001), but similar Apo B-100 levels (104.84mg/dl+/-7.05mg/dl vs. 102.39mg/dl+/-8.08mg/dl, p=0.118).

  4. Higher level of some risk factors like PAB values, apoB/A1 ratio concentration, and lipid profiles is able to involve in the prognostic pathological consequences in patients with beta-thalassemia major. Even so, they contribute toward the gradual development of CVD.

  5. Multiple novel LDLR (show LDLR Antibodies) and ApoB mutations have been identified in a-United Kingdom-based cohort with familial hypercholesterolemia.

  6. Data suggest that LDL-C/apoB ratio (ratio of plasma level of total cholesterol to plasma level of apolipoprotein B) is an important biomarker in overall evaluation of atherogenicity in obese, overweight, and normal-weight men; this study of qualitative changes in lipid/lipoprotein profile for early diagnosis of dyslipidemias leading to atherosclerosis was conducted in Russia.

  7. Mutations in APOB is associated with hypobetalipoproteinemia.

  8. LDLR (show LDLR Antibodies) A(+)A(+) genotype, ApoB X(+) allele and ApoE (show APOE Antibodies) E4 allele increased the risk of premature coronary artery disease by 1.8, 2.1 and 12.1 respectively.

  9. C7673T polymorphism in apoB gene is significantly associated with increased ischemic stroke risk in the Chinese population.

  10. Apo (show C9orf3 Antibodies)-B correlation with both LDL-C and non-HDL (show HSD11B1 Antibodies)-C is reduced in individuals with high TG levels and in particular for those with diabetes or MetS (show ETV3 Antibodies).

Cow (Bovine) Apolipoprotein B (APOB) interaction partners

  1. Cholesterol deficiency results from a 1.3kbp insertion of an endogenous retrovirus (ERV2-1-LTR_BT) into exon 5 of the APOB gene at BTA11:77,959kb. The insertion is flanked by 6bp target site duplications as described for insertions mediated by retroviral integrases.

  2. A transposable element insertion in APOB causes cholesterol deficiency in Holstein cattle

  3. Nonesterified fatty acids significantly inhibit the expression of ApoB100, ApoE (show APOE Antibodies), MTP (show MTTP Antibodies), and LDLR (show LDLR Antibodies), thereby decreasing the synthesis and assembly of VLDL and inducing TG accumulation in bovine hepatocytes.

  4. after calving the apolipoprotein B(100) mRNA synthesis was lower, whereas microsomal triglyceride transfer protein (MTP (show MTTP Antibodies)) and apolipoprotein E (show APOE Antibodies) messenger RNA abundance were higher in the liver.

Mouse (Murine) Apolipoprotein B (APOB) interaction partners

  1. We carried out our experiment in mice deficient in the low density lipoprotein (LDL) receptor (show LDLR Antibodies) and expressing only ApoB100 molecule (ApoB - LDLr (show LDLR Antibodies)) where the development of atherosclerosis is known to closely mimic human atherosclerosis

  2. The effect of hypercholesterolemia induced immune response and inflammation on progression of atherosclerosis in ApoB(tm25gy) LDLr (show LDLR Antibodies)(tm1Her) mice, expressing only ApoB100 and deficient in the low density lipoprotein receptor (show LDLR Antibodies).

  3. ApoB-containing lipoproteins contribute to augmentation of AngII-induced abdominal aortic aneurysms in male mice.

  4. Immunization with human apolipoprotein B100 (ApoB) resulted in four-fold increased accumulation of effector T cells in ApoB-containing matrigel

  5. PCSK9 (show PCSK9 Antibodies) markedly increases intestinal triglyceride-rich apoB production through mechanisms mediated in part by transcriptional effects on apoB.

  6. Mice that produce apoB100 in the RPE (show RPE Antibodies) and liver secrete lipoproteins into Bruch's membrane, but not to the extent that distinct features of AMD (show AMD1 Antibodies) develop

  7. The aim of this study was to characterize the ocular morphology of low-density lipoprotein receptor-deficient apolipoprotein B-100-only mice, with IGF-II overexpression.

  8. Our data establish the role of APOB gene in severe gut (show GUSB Antibodies) dysmotility.

  9. Cardiac lipotoxicity may originate from direct inhibition of myocardial ApoB lipoprotein and subsequent decreased lipid export, caused by supraphysiological levels of catecholamines.

  10. ApoB-100 transgenic animals present i) elevated serum and cerebral levels of triglycerides and ApoB-100, ii) increased cerebral tau phosphorylation at phosphosites Ser (show SIGLEC1 Antibodies)(199), Ser (show SIGLEC1 Antibodies)(199/202), Ser (show SIGLEC1 Antibodies)(396) and Ser (show SIGLEC1 Antibodies)(404).

Pig (Porcine) Apolipoprotein B (APOB) interaction partners

  1. found association between genotypes for LDLR (show LDLR Antibodies) and APOB polymorphisms and serum lipid levels, but none of them seem to be the causal mutation but probably represent closely linked polymorphisms

APOB Antigen Profile

Protein Summary

This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels.

Gene names and symbols associated with anti-Apolipoprotein B (APOB) Antibodies

  • apolipoprotein B (APOB) antibody
  • apolipoprotein B (Apob) antibody
  • apolipoprotein B (including Ag(x) antigen) (APOB) antibody
  • Ac1-060 antibody
  • AI315052 antibody
  • ApoB(100) antibody
  • apob-48 antibody
  • Apo B-100 antibody
  • apob-100 antibody
  • FLDB antibody
  • LDLCQ4 antibody

Protein level used designations for anti-Apolipoprotein B (APOB) Antibodies

apo B-100 , apoB-100 , apoB-48 , apolipoprotein B (including Ag(x) antigen) , apolipoprotein B-100 , apolipoprotein B48 , mutant Apo B 100 , apolipoprotein B PI , apolipoprotein B-48 , apolipoprotein B

338 Homo sapiens
54225 Rattus norvegicus
494004 Bos taurus
100725937 Cavia porcellus
238055 Mus musculus
100523371 Sus scrofa
100009101 Oryctolagus cuniculus
475680 Canis lupus familiaris
101107590 Ovis aries
396535 Gallus gallus
Selected quality suppliers for anti-APOB (APOB) Antibodies
Did you look for something else?